Daewoong Pharmaceutical CEO Lee Changjae Wins UNFISCO SDGs Award

From "Remote Patient Monitoring" to "Remote Home Monitoring"
Building a Nationwide 24-Hour Health Management System

Daewoong Pharmaceutical announced on the 30th that CEO Lee Changjae was selected as the recipient of the "Good Health & Well-being" category at the 2025 SDGs (Sustainable Development Goals) Awards hosted by UNFISCO.

This award is given based on an evaluation of the achievements of companies and individuals according to the Sustainable Development Goals set by the United Nations. CEO Lee was recognized for his accomplishments in establishing a nationwide 24-hour health management system based on remote monitoring and in advancing ESG initiatives through digital healthcare, thereby leading improvements in patient safety and quality of life.

Lee Changjae, CEO of Daewoong Pharmaceutical, is receiving the award in the "Health and Well-being" category at the 2025 SDGs Awards hosted by UNFISCO on the 29th. Daewoong Pharmaceutical

CEO Lee has presented a future vision of building a digital healthcare infrastructure that enables everyone to access health management services anytime and anywhere by integrating AI and real-time biometric data analysis technologies into the entire cycle of health management, from disease prevention to early diagnosis, treatment, and post-care.

At the core of this strategy is Daewoong Pharmaceutical’s smart bed monitoring system, thynC™. ThynC™ continuously collects key vital signs such as blood pressure, pulse, respiration, body temperature, and oxygen saturation through wearable biosensors 24 hours a day. When the AI algorithm detects abnormal signs, it immediately notifies medical staff. Recently, the system has been integrated with devices such as the ring-type continuous blood pressure monitor CartBP and the voice-recognition-based AI medical record automation solution GenNOTE, creating a precision care environment where patient medical information and biometric data are integrated in real time.

Daewoong Pharmaceutical plans to expand this "remote patient monitoring system" beyond hospitalized patients to "remote home monitoring" for post-discharge care, thereby establishing a nationwide 24-hour health management system. This approach is being recognized as a new solution for improving medical accessibility and efficiently utilizing healthcare resources at a national level in the era of an aging population and chronic diseases.

Along with the spread of digital healthcare, CEO Lee has actively led ESG initiatives to address healthcare blind spots and promote health equity. Daewoong Pharmaceutical has provided volunteer medical services using AI wearable digital devices in island regions with limited medical access, and has operated systematic health checkups, consultations, and personalized management programs for North Korean defectors.

In particular, the company supports vulnerable groups in the aging society by enabling early detection and management of health issues common among the elderly, such as heart failure, arrhythmia, glaucoma, macular degeneration, sarcopenia, and sleep apnea, especially in island and rural areas.

Additionally, through the "SAVE THE HERO" campaign to prevent sudden cardiac death among police officers, Daewoong Pharmaceutical is raising awareness of the importance of early arrhythmia detection and heart health management, and is leading efforts to protect the health of high-risk occupations by supporting free screenings using the wearable electrocardiogram device Mobicare.

In his acceptance speech, CEO Lee stated, "Daewoong Pharmaceutical plans to expand the remote patient monitoring system currently operated in hospitals to home care, thereby establishing a nationwide 24-hour health management system. We will become a health assistant by the side of the people, take the lead in opening a new medical paradigm, and be a company that stands together with patients."

This content was produced with the assistance of AI translation services.